Kyverna Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VIDA VENTURES ADVISORS, LLC | 01/21/2025 | 4.52 M | $16.92 M | 0.00% | 10.48% |
GILEAD SCIENCES, INC. | 02/13/2025 | 4.13 M | $15.43 M | 100.00% | 9.56% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 3.37 M | $12.60 M | 0.00% | 7.81% |
NOVO HOLDINGS A/S | 02/14/2025 | 1.85 M | $6.92 M | 0.00% | 4.29% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 1.67 M | $6.26 M | 10.01% | 3.88% |
INSIGHT HOLDINGS GROUP, LLC | 02/14/2025 | 912,915 | $3.41 M | 0.00% | 2.12% |
FRANKLIN RESOURCES INC | 02/12/2025 | 692,028 | $2.59 M | -26.14% | 1.60% |
MBB PUBLIC MARKETS I LLC | 02/14/2025 | 614,477 | $2.30 M | 0.00% | 1.42% |
02/14/2025 | 586,909 | $2.20 M | 100.00% | 1.36% | |
01/15/2025 | 376,131 | $1.41 M | 100.00% | 0.87% | |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 350,000 | $1.31 M | 75.00% | 0.81% |
SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 182,177 | $681,342 | 100.00% | 0.42% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 178,963 | $669,322 | 0.00% | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 118,758 | $444,155 | -52.24% | 0.28% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 90,242 | $337,505 | 0.00% | 0.21% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 90,235 | $337,479 | 102.20% | 0.21% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 45,000 | $168,300 | 0.00% | 0.10% |
XTX TOPCO LTD | 02/13/2025 | 43,949 | $164,369 | -16.75% | 0.10% |
PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 43,762 | $163,670 | 104.54% | 0.10% |
ALPS ADVISORS INC | 02/13/2025 | 34,912 | $130,571 | 5.61% | 0.08% |
CAXTON CORP | 02/14/2025 | 22,981 | $85,950 | 0.00% | 0.05% |
MARSHALL WACE, LLP | 02/13/2025 | 15,241 | $57,001 | -52.70% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 14,288 | $53,437 | 53.67% | 0.03% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 12,811 | $47,913 | 42.33% | 0.03% |
CORTON CAPITAL INC. | 02/14/2025 | 12,099 | $45,250 | 100.00% | 0.03% |
SQUAREPOINT OPS LLC | 02/14/2025 | 11,488 | $42,965 | 100.00% | 0.03% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 9,154 | $34,236 | 100.00% | 0.02% |
DEKABANK DEUTSCHE GIROZENTRALE | 01/29/2025 | 7,500 | $171,000 | 0.00% | 0.02% |
02/11/2025 | 3,385 | $12,660 | 100.00% | 0.01% | |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 1,439 | $5,742 | 100.00% | 0.00% |
02/19/2025 | 906 | $3,388 | 100.00% | 0.00% | |
AMALGAMATED BANK | 02/04/2025 | 582 | $2,000 | 0.00% | 0.00% |
02/18/2025 | 250 | $935 | 100.00% | 0.00% | |
01/23/2025 | 240 | $898 | 100.00% | 0.00% | |
STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 233 | $871 | 628.13% | 0.00% |
02/06/2025 | 140 | $524 | 100.00% | 0.00% | |
ROTHSCHILD INVESTMENT LLC | 02/04/2025 | 105 | $393 | 100.00% | 0.00% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SECTORAL ASSET MANAGEMENT INC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SIGNATUREFD, LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
ALLWORTH FINANCIAL LP | 01/30/2025 | 0 | $0 | -100.00% | 0.00% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
VIRTUS ETF ADVISERS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
Kyverna Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 54 institutional investors and hedge funds held shares of Kyverna Therapeutics, Inc.. The most heavily invested institutionals were:
Vida Ventures Advisors, LLC: 4.52 M
GILEAD SCIENCES, INC.: 4.13 M
Bain Capital Life Sciences Investors, LLC: 3.37 M
Novo Holdings A/S: 1.85 M
BlackRock Funding, Inc. /DE: 1.67 M
Insight Holdings Group, LLC: 912,915
66.89% of Kyverna Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 22.30 M shares in the last 24 months. This purchase volume represents approximately $84.97 M in transactions.